Literature DB >> 30556154

Improvement in infected wound healing in type 1 diabetic rat by the synergistic effect of photobiomodulation therapy and conditioned medium.

Mohammadjavad Fridoni1, Reza Kouhkheil1, Mohammad-Amin Abdollhifar2, Abdollah Amini2, Mahdi Ghatrehsamani3, Seyed Kamran Ghoreishi4, Sufan Chien5, Sahar Bayat6, Mohammad Bayat2.   

Abstract

We investigated the effects of photobiomodulation therapy (PBMT) and conditioned medium (CM) of human bone marrow mesenchymal stem cells (hBM-MSC) individually and/or in combination on the stereological parameters and the expression of basic fibroblast growth factor (bFGF), hypoxia-inducible factor (HIF-1α), and stromal cell-derived factor-1α (SDF-1α) in a wound model infected with methicillin-resistant Staphylococcus aureus (MRSA) in diabetic rats. CM was provided by culturing hBM-MSCs. Type 1 diabetes mellitus (T1DM) was induced in 72 rats, divided into four groups, harboring 18 rats each: group 1 served as a control group, group 2 received PBMT, group 3 received CM, and group 4 received CM + PBMT. On days 4, 7, and 15, six animals from each group were euthanized and the skin samples were separated for stereology examination and gene expression analysis by real-time polymerase chain reaction. In the CM + PBMT, CM, and PBMT groups, significant decreases were induced in the number of neutrophils (1460 ± 93, 1854 ± 138, 1719 ± 248) and macrophages (539 ± 69, 804 ± 63, 912 ± 41), and significant increases in the number of fibroblasts (1073 ± 116, 836 ± 75, 912 ± 41) and angiogenesis (15 230 ± 516, 13 318 ± 1116, 14 041 ± 867), compared with those of the control group (2690 ± 371, 1139 ± 145, 566 ± 90, 12 585 ± 1219). Interestingly, the findings of the stereological examination in the CM + PBMT group were statistically more significant than those in the other groups. In the PBMT group, in most cases, the expression of bFGF, HIF-1α, and SDF-1α, on day 4 (27.7 ± 0.14, 28.8 ± 0.52, 27.5 ± 0.54) and day 7 (26.8 ± 1.4, 29.6 ± 1.4, 28.3 ± 1.2) were more significant than those in the control (day 4, 19.3 ± 0.42, 25.5 ± 0.08, 22.6 ± 0.04; day 7, 22.3 ± 0.22, 28.3 ± 0.59, 24.3 ± 0.19) and other treatment groups. The application of PBMT + CM induced anti-inflammatory and angiogenic activities, and hastened wound healing process in a T1 DM model of MRSA infected wound.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  diabetes mellitus; diabetic foot ulcer; human bone marrow mesenchymal stem cell-conditioned medium; low-level laser therapy; methicillin-resistant staphylococcal aureus; phobiomodulation therapy; rat; real-time PCR; stereology

Year:  2018        PMID: 30556154     DOI: 10.1002/jcb.28273

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

1.  Topical Transplantation of Bone Marrow Mesenchymal Stem Cells Made Deeper Skin Wounds Regeneration.

Authors:  Qin Yonghong; Li Aishu; Yazan Al-Ajam; Liao Yuting; Zhang Xuanfeng; Zhang Jin
Journal:  Plast Surg (Oakv)       Date:  2020-10-27       Impact factor: 0.947

Review 2.  Potential of stem cells for treating infected Diabetic Foot Wounds and Ulcers: a systematic review.

Authors:  Abdollah Amini; Sufan Chien; Mohammad Bayat
Journal:  Mol Biol Rep       Date:  2022-08-25       Impact factor: 2.742

Review 3.  Effectiveness of preconditioned adipose-derived mesenchymal stem cells with photobiomodulation for the treatment of diabetic foot ulcers: a systematic review.

Authors:  Abdollah Amini; Sufan Chien; Mohammad Bayat
Journal:  Lasers Med Sci       Date:  2021-10-26       Impact factor: 3.161

4.  Combined therapy of photobiomodulation and adipose-derived stem cells synergistically improve healing in an ischemic, infected and delayed healing wound model in rats with type 1 diabetes mellitus.

Authors:  Roohollah Ebrahimpour-Malekshah; Abdollah Amini; Fatemeh Zare; Atarodsadat Mostafavinia; Samin Davoody; Niloofar Deravi; Mohammad Rahmanian; Seyed Mahmoud Hashemi; Malihe Habibi; Seyed Kamran Ghoreishi; Sufan Chien; Sasha Shafikhani; Houssein Ahmadi; Sahar Bayat; Mohammad Bayat
Journal:  BMJ Open Diabetes Res Care       Date:  2020-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.